India · Delayed Price · Currency is INR Poly Medicure Statistics
Total Valuation
Poly Medicure has a market cap or net worth of INR 190.11 billion. The enterprise value is 181.69 billion.
| Market Cap | 190.11B |
| Enterprise Value | 181.69B |
Important Dates
The last earnings date was Saturday, November 8, 2025.
| Earnings Date | Nov 8, 2025 |
| Ex-Dividend Date | Sep 18, 2025 |
Share Statistics
Poly Medicure has 101.36 million shares outstanding. The number of shares has increased by 5.60% in one year.
| Current Share Class | 101.36M |
| Shares Outstanding | 101.36M |
| Shares Change (YoY) | +5.60% |
| Shares Change (QoQ) | -0.14% |
| Owned by Insiders (%) | 40.02% |
| Owned by Institutions (%) | 23.75% |
| Float | 33.26M |
Valuation Ratios
The trailing PE ratio is 52.69 and the forward PE ratio is 45.71. Poly Medicure's PEG ratio is 2.07.
| PE Ratio | 52.69 |
| Forward PE | 45.71 |
| PS Ratio | 11.10 |
| PB Ratio | 6.48 |
| P/TBV Ratio | 7.22 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 71.34 |
| PEG Ratio | 2.07 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 39.36, with an EV/FCF ratio of -265.20.
| EV / Earnings | 50.19 |
| EV / Sales | 10.61 |
| EV / EBITDA | 39.36 |
| EV / EBIT | 48.92 |
| EV / FCF | -265.20 |
Financial Position
The company has a current ratio of 3.89, with a Debt / Equity ratio of 0.08.
| Current Ratio | 3.89 |
| Quick Ratio | 3.04 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | 0.53 |
| Debt / FCF | -3.50 |
| Interest Coverage | 32.86 |
Financial Efficiency
Return on equity (ROE) is 13.11% and return on invested capital (ROIC) is 7.70%.
| Return on Equity (ROE) | 13.11% |
| Return on Assets (ROA) | 6.87% |
| Return on Invested Capital (ROIC) | 7.70% |
| Return on Capital Employed (ROCE) | 11.83% |
| Revenue Per Employee | 5.56M |
| Profits Per Employee | 1.17M |
| Employee Count | 3,082 |
| Asset Turnover | 0.52 |
| Inventory Turnover | 1.82 |
Taxes
In the past 12 months, Poly Medicure has paid 1.19 billion in taxes.
| Income Tax | 1.19B |
| Effective Tax Rate | 24.71% |
Stock Price Statistics
The stock price has decreased by -27.95% in the last 52 weeks. The beta is 0.01, so Poly Medicure's price volatility has been lower than the market average.
| Beta (5Y) | 0.01 |
| 52-Week Price Change | -27.95% |
| 50-Day Moving Average | 1,937.72 |
| 200-Day Moving Average | 2,147.02 |
| Relative Strength Index (RSI) | 43.93 |
| Average Volume (20 Days) | 11,321 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Poly Medicure had revenue of INR 17.12 billion and earned 3.62 billion in profits. Earnings per share was 35.60.
| Revenue | 17.12B |
| Gross Profit | 11.51B |
| Operating Income | 3.65B |
| Pretax Income | 4.81B |
| Net Income | 3.62B |
| EBITDA | 4.54B |
| EBIT | 3.65B |
| Earnings Per Share (EPS) | 35.60 |
Balance Sheet
The company has 10.96 billion in cash and 2.40 billion in debt, giving a net cash position of 8.57 billion or 84.54 per share.
| Cash & Cash Equivalents | 10.96B |
| Total Debt | 2.40B |
| Net Cash | 8.57B |
| Net Cash Per Share | 84.54 |
| Equity (Book Value) | 29.32B |
| Book Value Per Share | 287.91 |
| Working Capital | 14.46B |
Cash Flow
In the last 12 months, operating cash flow was 2.66 billion and capital expenditures -3.35 billion, giving a free cash flow of -685.10 million.
| Operating Cash Flow | 2.66B |
| Capital Expenditures | -3.35B |
| Free Cash Flow | -685.10M |
| FCF Per Share | -6.76 |
Margins
Gross margin is 67.24%, with operating and profit margins of 21.32% and 21.14%.
| Gross Margin | 67.24% |
| Operating Margin | 21.32% |
| Pretax Margin | 28.08% |
| Profit Margin | 21.14% |
| EBITDA Margin | 26.49% |
| EBIT Margin | 21.32% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 3.50, which amounts to a dividend yield of 0.19%.
| Dividend Per Share | 3.50 |
| Dividend Yield | 0.19% |
| Dividend Growth (YoY) | 16.67% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 8.38% |
| Buyback Yield | -5.60% |
| Shareholder Yield | -5.41% |
| Earnings Yield | 1.90% |
| FCF Yield | -0.36% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 24, 2017. It was a forward split with a ratio of 2.
| Last Split Date | Mar 24, 2017 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |